Lawsuits over defective Stryker Rejuvenate, ABG II component parts centralized in NJ court system


Lawsuits tied to the Stryker Rejuvenate and ABG II hip implant components have been centralized in one New Jersey Superior Court.

New Jersey Supreme Court recently ruled that  lawsuits filed in the state against medical device maker Stryker Corp. concerning its recalled hip implant components will now be centralized in Bergen County Superior Court as part of a Multicounty Litigation. Multicounty Litigation centralizes the pre-trial portions of multiple lawsuits making similar claims much in the same way a Multidistrict Litigation does for federal lawsuits.

More people have begun filing lawsuits against Stryker Corp. over its defective Rejuvenate and ABG II implant component parts since the company recalled them last year. The lawsuits claim the company hid evidence of their dangers and marketed each part as safe and effective despite knowing recipients faced a high injury risk and that the devices were prone to failures that resulted in severe pain and disability.

The Rejuvenate and ABG II implant components were recalled in July 2012 when Stryker announced the devices were prone to fretting and corrosion. These defects caused increased levels of metallic ions to be dispersed into a recipient’s bloodstream and potentially lead to tissue and organ damage. Recipients were also likely to experience severe pain and would have to consider a surgery to replace the devices and risk losing full mobility in the future while impairing them as they continued to wear the devices.